VERA•benzinga•
HC Wainwright & Co. Initiates Coverage On Vera Therapeutics with Buy Rating, Announces Price Target of $35
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2022 by benzinga